McDonnell Boehnen Hulbert & Berghoff LLP partner Sherri Oslick is quoted in a February 15, 2017 edition of BioCentury.com in an article entitled, “UC undeterred by CRISPR patent ruling.” A University of California group is optimistic that its CRISPR IP rights will cover use of the technology in all cell types, despite a U.S. patent board’s ruling Wednesday that an opposing group’s IP is patentable separately. View the article